Guillain-Barré syndrome associated with COVID-19 disease.
Sindhuja KoremHaresh GandhiDecerie Baculi DayagPublished in: BMJ case reports (2020)
Clinical manifestations of COVID-19 are known to be variable with growing evidence of nervous system involvement. In this case report, we describe the symptoms of a patient infected with SARS-CoV-2 whose clinical course was complicated with Guillain-Barré syndrome (GBS). We present a case of a 58-year-old woman who was initially diagnosed with COVID-19 pneumonia due to symptoms of fever and cough. Two weeks later, after the resolution of upper respiratory tract symptoms, she developed symmetric ascending quadriparesis and paresthesias. The diagnosis of GBS was made through cerebrospinal fluid analysis and she was successfully treated with intravenous immunoglobulin administration.
Keyphrases
- sars cov
- case report
- coronavirus disease
- respiratory tract
- respiratory syndrome coronavirus
- cerebrospinal fluid
- sleep quality
- intensive care unit
- single molecule
- coronary artery
- low dose
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- pulmonary arterial hypertension
- aortic dissection
- mechanical ventilation